# Seysara

NDC: 16110-247
Generic name: sarecycline hydrochloride
Labeler / Manufacturer: Almirall, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, COATED
Routes: ORAL
Marketing started: 20190104

FDA application: NDA209521

## Active ingredients

- SARECYCLINE HYDROCHLORIDE: 150 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"16110-247"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=16110-247
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b200957c-3004-4988-be97-9fd619a83649